510(k) Report

510(k) · Cleared

Cleared

MEMO 4D Curve™ Semirigid mitral annuloplasty ring

K261707510(k) SpecialCleared Jun 18, 202627-day reviewClass II21 CFR 870.3800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Corcym S.r.l. · KRH Ring, Annuloplasty

Cleared on Jun 18, 2026 as substantially equivalent to K230318 (Corcym S.r.l., 2023) after a 27-day review. Its family tree reaches back 5 generations to 1993.

Decided
Jun 18, 2026
Review
27 days
Class
Class II
Product code
KRH
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K926138 (1993). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK926138 Carpentier-Edwards Physio Annuloplasty RingBaxter Healthcare Corp · 1993
  2. 4 generations backK071327 Memo 3D Semirigid Annuloplasty RingSorin Biomedica Cardio S.R.L. · 2007
  3. 3 generations backK142221 MEMO 3D ReChordSorin Group Italia S.R.L. · 2014
  4. 2 generations backK180411 MEMO 4DSorin Group Italia S.R.L. · 2018
  5. 1 generation backK230318 Memo 3D Semirigid Annuloplasty Ring; Memo 3D ReChord Semirigid…Corcym S.r.l. · 2023
  6. This deviceK261707 MEMO 4D Curve™ Semirigid mitral annuloplasty ringCorcym S.r.l. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K926138Carpentier-Edwards Physio Annuloplasty RingBaxter Healthcare Corp1993—
−4K071327Memo 3D Semirigid Annuloplasty RingSorin Biomedica Cardio S.R.L.2007—
−3K142221MEMO 3D ReChordSorin Group Italia S.R.L.2014—
−2K180411MEMO 4DSorin Group Italia S.R.L.2018—
−1K230318Memo 3D Semirigid Annuloplasty Ring; Memo 3D ReChord Semirigid Annuloplasty…Corcym S.r.l.2023—
0 (this device)K261707MEMO 4D Curve™ Semirigid mitral annuloplasty ringCorcym S.r.l.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200220
FIG. 1 — Lineage of K261707, 1993–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRH device

  1. #1 K260498 TriMemo™ SEMIRIGID ANNULOPLASTY RINGscore 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K230318Memo 3D Semirigid Annuloplasty Ring; Memo 3D ReChord Semirigid Annuloplasty Ring; Memo…
Summary page 5
…n Number: 870.3800 Product Code(s): KRH III. Legally Marketed Predicate Devices — 21 CFR 807.92(a)(3) Predicate #: K230318 Predicate Trade Name: Memo 4D Semirigid Annuloplasty Ring Product Code: KRH IV. Device Descrip…
Corcym S.r.l.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 4 companies; a new generation was cleared every 5.1 years on median.
  • None of the 8 ancestors has a recall.

How does its category compare?

All KRH devices

KRH Ring, Annuloplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · KRH

4in 2025

2007: 42008: 22009: 82010: 22011: 22014: 12016: 12018: 22019: 22020: 22023: 22024: 12025: 42026 (partial year): 2
2007high 8 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRH

98in 2025

2007: 90 days median2009: 68 days median2025: 98 days median
2007high 98 (2025) · low 68 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRH

No recall names KRH since 2007.

Adverse event reports per year · KRH

420in 2025

2007: 2612008: 1,2882009: 9732010: 6302011: 3212012: 902013: 972014: 732015: 1452016: 3472017: 3792018: 3782019: 3492020: 3402021: 4232022: 3722023: 3242024: 4072025: 420
2007high 1,288 (2008) · low 73 (2014)2025

MAUDE reports naming product code KRH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074900261
20082—01,288
20098680973
20102—0630
20112—0321
20120—090
20130—097
20141—073
20150—0145
20161—0347
20170—0379
20182—0378
20192—0349
20202—0340
20210—0423
20220—0372
20232—0324
20241—0407
20254980420
20262—0—

What is it indicated for?

MEMO 4D Curve is indicated for use in patients suffering from congenital or acquired mitral insufficiencies or steno-insufficiencies with dilatation and/or deformation of the mitral annulus.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K261707: MEMO 4D Curve™ Semirigid mitral annuloplasty ring.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K261707

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026